CYRX Stock Summary and Trading Ideas (Cryoport | NASDAQ:CYRX)

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Cryoport trades on the NASDAQ stock market under the symbol CYRX.

As of September 11, 2026, CYRX stock price climbed to $15.55 with 439,574 million shares trading.

CYRX has a beta of 1.79, meaning it tends to be more sensitive to market movements. CYRX has a correlation of 0.17 to the broad based SPY ETF.

CYRX has a market cap of $787.59 million. This is considered a Small Cap stock.

Last quarter Cryoport reported $49 million in Revenue and -$.20 earnings per share. This beat revenue expectation by $786,824 and missed earnings estimates by -$.01.

In the last 3 years, CYRX traded as high as $20.11 and as low as $4.58.

The top ETF exchange traded funds that CYRX belongs to (by Net Assets): VTI, VXF, VTWO, SCHA, DFAS.

CYRX has outperformed the market in the last year with a return of +64.2%, while the SPY ETF gained +17.4%. In the last 3 month period, CYRX beat the market returning +8.1%, while SPY returned +3.9%. However, in the most recent 2 weeks CYRX has underperformed the stock market by returning -3.4%, while SPY returned -0.7%.

CYRX support price is $14.84 and resistance is $15.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYRX shares will trade within this expected range on the day.